• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

PLOS Pathogens retracts Flaviviridae methylation study

by
November 9, 2026
in Biology, Health
Reading Time: 3 mins read
0
PLOS Pathogens retracts Flaviviridae methylation study

PLOS Pathogens retracts Flaviviridae methylation study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The PLOS Pathogens Editors have issued a retraction notice for an article titled “Flaviviridae RdRp exploits NSUN2-driven m5C methylation to establish persistent infection.” The retraction was published on November 9, 2026, following a review of concerns raised about the reliability and integrity of the results presented in the original publication. The decision to retract the article was made by the journal editors based on unresolved issues regarding specific figures and data integrity.

The retraction notice identifies that concerns were raised after the original article was published regarding results presented in Figures 1, 3, S6, S8, S10, and S21. These figures contain various experimental data, including western blot panels and confocal microscopy line graphs. The specific nature of the concerns involves potential similarities between panels that should represent distinct experimental conditions, as well as repetitive areas within graphical data.

One specific concern noted in the retraction notice is that the Lung β-actin panel in Figure 1E appears similar to the WCL β-actin panel in Figure 3G. Additionally, there appear to be similarities between parts of confocal microscopy line graphs, specifically between Fig S6F NS4B and Fig S6F NS5A, and between Fig S8A NS1 and Fig S8A NS2B. These visual similarities raised questions about the distinctness of the experimental conditions represented in the data.

Further scrutiny of the confocal microscopy line graphs revealed repetitive areas in several figures, including Fig S8B NS3, Fig S8B NS4B, Fig S8B NS5A, Fig S8C Vector, Fig S10B CSFV-NS5B, and Fig S10E ML-792. These graphical anomalies contributed to the editorial review of the data’s integrity.

Another significant concern involved the Npro panel in Figure S21B of the retracted article, which appears similar to the Npro panel in Figure 8B of a separate publication, despite representing different experimental conditions. The corresponding author stated that the Fig 1E Lung β-actin panel was incorrect and provided underlying data and a replacement panel. Regarding the confocal microscopy graphs, the corresponding author provided replacement graphs plotted from a reanalysis of the original images. However, upon editorial review, the data provided did not resolve the concerns regarding these graphs.

The corresponding author also stated that the Fig S21B panel was incorrect and provided a replacement panel along with underlying uncropped blot data. However, the underlying blot provided raised additional concerns with the results in Fig S21B. In light of these unresolved issues, which question the reliability and integrity of the reported results, the PLOS Pathogens Editors decided to retract the article. The retraction notice explicitly states that the authors did not agree with the retraction and stand by the article’s findings.

In addition to the specific figure concerns, the retraction notice mentions that concerns were raised about discontinuities in the background of multiple western blot panels in the original article. Due to the other unresolved concerns regarding the figures and data integrity, PLOS did not investigate the blot discontinuity concerns further.

The retraction notice is attributed to the PLOS Pathogens Editors and is identified as an Article type publication. The original article had an Open Access designation. The DOI for the retraction notice is 10.1371/journal.ppat.1014764.

Subject of Research: Retraction of a Flaviviridae research article due to data integrity concerns

Article Title: Retraction: Flaviviridae RdRp exploits NSUN2-driven m 5 C methylation to establish persistent infection

Article References: The PLOS Pathogens Editors (2026). Retraction: Flaviviridae RdRp exploits NSUN2-driven m5C methylation to establish persistent infection. PLOS Pathogens, 22(11), e1014764. https://doi.org/10.1371/journal.ppat.1014764

Image Credits: AI Generated

DOI: 10.1371/journal.ppat.1014764

Keywords: retraction, PLOS Pathogens, Flaviviridae, data integrity, scientific publishing, western blot, confocal microscopy, NSUN2, m5C methylation, editorial review, RdRp, exploits

News Source: Drew Townsend. (November 9, 2026). PLOS Pathogens retracts Flaviviridae methylation study. Scienmag.

Tags: confocal microscopydata integrityeditorial reviewexploitsflaviviridaem5C methylationNSUN2PLOS PathogensRdRpRetractionscientific publishingwestern blot
Share12Tweet7Share2ShareShareShare1

Related Posts

Distally Based Medial Leg Flaps Maintained Coverage in Small Ankle Study

Distally Based Medial Leg Flaps Maintained Coverage in Small Ankle Study

November 10, 2026
Eastern European Oncology Panel Evaluates Metastatic Colorectal Cancer Management and Fruquintinib Adoption

Eastern European Oncology Panel Evaluates Metastatic Colorectal Cancer Management and Fruquintinib Adoption

November 10, 2026

Bacterial Enzyme Covalently Captures Food Carcinogen Acrylamide via Surface Cysteine Residue

November 10, 2026

Genetic Testing and Targeted Therapy Benefit Lung Squamous Cell Carcinoma Patients

November 10, 2026

POPULAR NEWS

  • Intranasal Lidocaine Spray Eases Nasogastric Tube Placement in Adult Emergency Patients

    Intranasal Lidocaine Spray Eases Nasogastric Tube Placement in Adult Emergency Patients

    29 shares
    Share 12 Tweet 7
  • Hospital Outbreaks Disseminate Ceftazidime-Avibactam and Cefiderocol Co-Resistant Klebsiella Pneumoniae Clones

    29 shares
    Share 12 Tweet 7
  • PET Imaging Shows Aging Reduces Human Brain Ascorbic Acid Transport via Choroid Plexus

    29 shares
    Share 12 Tweet 7
  • Plant Hemoglobin Expression Impairs Aerobic Guaiacol Bioconversion in Pseudomonas putida

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Distally Based Medial Leg Flaps Maintained Coverage in Small Ankle Study

Eastern European Oncology Panel Evaluates Metastatic Colorectal Cancer Management and Fruquintinib Adoption

Bacterial Enzyme Covalently Captures Food Carcinogen Acrylamide via Surface Cysteine Residue

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.